BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19710696)

  • 1. Mixed-lineage-leukemia (MLL) fusion protein collaborates with Ras to induce acute leukemia through aberrant Hox expression and Raf activation.
    Ono R; Kumagai H; Nakajima H; Hishiya A; Taki T; Horikawa K; Takatsu K; Satoh T; Hayashi Y; Kitamura T; Nosaka T
    Leukemia; 2009 Dec; 23(12):2197-209. PubMed ID: 19710696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistep pathogenesis of leukemia via the MLL-AF4 chimeric gene/Flt3 gene tyrosine kinase domain (TKD) mutation-related enhancement of S100A6 expression.
    Yamaguchi H; Hanawa H; Uchida N; Inamai M; Sawaguchi K; Mitamura Y; Shimada T; Dan K; Inokuchi K
    Exp Hematol; 2009 Jun; 37(6):701-14. PubMed ID: 19463771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimerization of MLL fusion proteins and FLT3 activation synergize to induce multiple-lineage leukemogenesis.
    Ono R; Nakajima H; Ozaki K; Kumagai H; Kawashima T; Taki T; Kitamura T; Hayashi Y; Nosaka T
    J Clin Invest; 2005 Apr; 115(4):919-29. PubMed ID: 15761502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.
    Yokoyama A; Somervaille TC; Smith KS; Rozenblatt-Rosen O; Meyerson M; Cleary ML
    Cell; 2005 Oct; 123(2):207-18. PubMed ID: 16239140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Ras-dependent Elk-1 activity by MLL-AF4 family fusion oncoproteins.
    Ng MH; Ng RK; Kong CT; Jin DY; Chan LC
    Exp Hematol; 2010 Jun; 38(6):481-8. PubMed ID: 20362031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein.
    Liu H; Chen B; Xiong H; Huang QH; Zhang QH; Wang ZG; Li BL; Chen Z; Chen SJ
    Oncogene; 2004 Apr; 23(19):3385-94. PubMed ID: 15077184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel infant acute lymphoblastic leukemia cell line with MLL-AF5q31 fusion transcript.
    Imamura T; Morimoto A; Ikushima S; Kakazu N; Hada S; Tabata Y; Yagi T; Inaba T; Hibi S; Sugimoto T; Imashuku S
    Leukemia; 2002 Nov; 16(11):2302-8. PubMed ID: 12399976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.
    Milne TA; Martin ME; Brock HW; Slany RK; Hess JL
    Cancer Res; 2005 Dec; 65(24):11367-74. PubMed ID: 16357144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
    Whelan JT; Ludwig DL; Bertrand FE
    Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression.
    Dou L; Zheng D; Li J; Li Y; Gao L; Wang L; Yu L
    Oncogene; 2012 Jan; 31(4):507-17. PubMed ID: 21706045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia.
    Liu T; Jankovic D; Brault L; Ehret S; Baty F; Stavropoulou V; Rossi V; Biondi A; Schwaller J
    Leukemia; 2010 Mar; 24(3):601-12. PubMed ID: 20072157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
    Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
    Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of growth factor receptor Flt3 in acute myeloid leukemia: transformation of myeloid cells by Ras-dependent and Ras-independent mechanisms].
    Müller-Tidow C; Steur C; Mizuki M; Schwäble J; Brandts C; Berdel WE; Serve H
    Dtsch Med Wochenschr; 2002 Oct; 127(42):2195-200. PubMed ID: 12397548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of MLL-associated leukemia.
    Yokoyama A
    Int J Hematol; 2015 Apr; 101(4):352-61. PubMed ID: 25773519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromodomain and histone acetyltransferase domain specificities control mixed lineage leukemia phenotype.
    Santillan DA; Theisler CM; Ryan AS; Popovic R; Stuart T; Zhou MM; Alkan S; Zeleznik-Le NJ
    Cancer Res; 2006 Oct; 66(20):10032-9. PubMed ID: 17047066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic dysregulation of leukaemic HOX code in MLL-rearranged leukaemia mouse model.
    Ng RK; Kong CT; So CC; Lui WC; Chan YF; Leung KC; So KC; Tsang HM; Chan LC; Sham MH
    J Pathol; 2014 Jan; 232(1):65-74. PubMed ID: 24122813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.
    Kumar AR; Hudson WA; Chen W; Nishiuchi R; Yao Q; Kersey JH
    Blood; 2004 Mar; 103(5):1823-8. PubMed ID: 14615372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hoxa9 collaborates with E2A-PBX1 in mouse B cell leukemia in association with Flt3 activation and decrease of B cell gene expression.
    Hassawi M; Shestakova EA; Fournier M; Lebert-Ghali CÉ; Vaisson G; Frison H; Sinnett D; Vidal R; Thompson A; Bijl JJ
    Dev Dyn; 2014 Jan; 243(1):145-58. PubMed ID: 23996689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
    Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
    Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
    Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
    Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.